Business Description
Bumrungrad Hospital PCL
ISIN : TH0168A10Z19
Description
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 117.9 | |||||
Equity-to-Asset | 0.82 | |||||
Debt-to-EBITDA | 0.01 | |||||
Interest Coverage | 3430.05 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 24.13 | |||||
Beneish M-Score | -1.02 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 27.1 | |||||
3-Year EBITDA Growth Rate | 53 | |||||
3-Year EPS without NRI Growth Rate | 79.8 | |||||
3-Year FCF Growth Rate | 62.3 | |||||
3-Year Book Growth Rate | 8.7 | |||||
Future 3-5Y Total Revenue Growth Rate | 6.55 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 100 | |||||
9-Day RSI | 99.97 | |||||
14-Day RSI | 98.45 | |||||
6-1 Month Momentum % | -7.06 | |||||
12-1 Month Momentum % | -5.9 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.75 | |||||
Quick Ratio | 3.66 | |||||
Cash Ratio | 2.57 | |||||
Days Inventory | 12.67 | |||||
Days Sales Outstanding | 62.4 | |||||
Days Payable | 39.14 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 2.07 | |||||
Dividend Payout Ratio | 0.22 | |||||
3-Year Dividend Growth Rate | 5 | |||||
Forward Dividend Yield % | 2.07 | |||||
5-Year Yield-on-Cost % | 2.62 | |||||
Shareholder Yield % | 1.99 |
Profitability Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 49.53 | |||||
Operating Margin % | 33.9 | |||||
Net Margin % | 28.09 | |||||
FCF Margin % | 22.68 | |||||
ROE % | 25.11 | |||||
ROA % | 20.47 | |||||
ROIC % | 39.17 | |||||
ROC (Joel Greenblatt) % | 54.46 | |||||
ROCE % | 29.34 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 34.27 | |||||
Forward PE Ratio | 23.64 | |||||
PE Ratio without NRI | 34.66 | |||||
Shiller PE Ratio | 46.92 | |||||
Price-to-Owner-Earnings | 44.52 | |||||
PEG Ratio | 4.28 | |||||
PS Ratio | 10.27 | |||||
PB Ratio | 7.63 | |||||
Price-to-Tangible-Book | 7.82 | |||||
Price-to-Free-Cash-Flow | 120.39 | |||||
Price-to-Operating-Cash-Flow | 106.63 | |||||
EV-to-EBIT | 24.24 | |||||
EV-to-Forward-EBIT | 20.46 | |||||
EV-to-EBITDA | 22.41 | |||||
EV-to-Forward-EBITDA | 20.23 | |||||
EV-to-Revenue | 8.4 | |||||
EV-to-Forward-Revenue | 7.07 | |||||
EV-to-FCF | 103.14 | |||||
Price-to-Projected-FCF | 4.55 | |||||
Price-to-Median-PS-Value | 1.13 | |||||
Price-to-Graham-Number | 3.59 | |||||
Price-to-Net-Current-Asset-Value | 17.94 | |||||
Price-to-Net-Cash | 33.89 | |||||
Earnings Yield (Greenblatt) % | 4.13 | |||||
FCF Yield % | 0.97 | |||||
Forward Rate of Return (Yacktman) % | 3.54 |